Skip to content

Cognitive Multisensory on Upper Extremity in Stroke

Cognitive Multisensory Rehabilitation on Upper Extremity Function in Stroke Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05485740
Enrollment
30
Registered
2022-08-03
Start date
2022-08-01
Completion date
2022-12-30
Last updated
2023-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

PURPOSE: To investigate the effect of cognitive multisensory rehabilitation program on upper extremity function in stroke patients. BACKGROUND: Cognitive Multisensory Rehabilitation (CMR) is a promising therapy for upper limb recovery in stroke, as the CMR considered an effective therapy for motor recovery for adults with stroke

Detailed description

Thirty patients with stroke The patients will randomly be divided into two equal groups; the control group which received the selected exercise program and the study group received the same exercise training program in addition to cognitive multisensory rehabilitation program, three times per week for 2 months. The evaluation methods Action research arm test (ARAT), Fugl-Myer Assessment upper extremity (FMA-UE), manual function test and Motor Evaluation Scale for Upper Extremity

Interventions

sensorimotor rehabilitation approach, in which the patient is asked to solve sensory discrimination exercises with closed eyes or to solve multisensory discrimination exercises, e.g., by comparing feeling shapes with seeing shapes.

OTHERthe selected exercise program

Upper Extremity Range of motion (ROM) exercises Passive Prolonged Stretching and positioning Weight-bearing exercise

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

the control group which received the selected exercise program and the study group received the same exercise training program in addition to cognitive multisensory rehabilitation program

Eligibility

Sex/Gender
ALL
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

1. Thirty hemiplegic patients, with the onset of stroke six months or longer. 2. Both sexes, with ages ranging from 45: 60. 3. Body mass index will range from 18.5-to 29.9 Kg/m2.

Exclusion criteria

1. Other brain injuries/illnesses, cognitive impairment, severe sensory or proprioceptive loss. 2. Other causes of hemiplegia. 3. Other causes of upper extremity dysfunction.

Design outcomes

Primary

MeasureTime frameDescription
Action research arm test8 weeksone of the most commonly used upper limb outcomes that measure the activity level in stroke rehabilitation studies consists of a total of 19 functional materials and four subtests as follows: grasp, grip, pinch, and gross movement
Fugl Myer Assessment upper extremity8 weeksis a scale consisting of 30 items assessing motor function and 3 items assessing reflex function The FMA-UE scores of 0 through 22 represent no upper-limb capacity; scores of 23 through 31 represent poor capacity; scores of 32 through 47 represent limited capacity; scores of 48 through 52 represent notable capacity; and scores of 53 through 66 represent full upper-limb capacity, total sensation UE score 12, passive joint motion UE score 24 and UE joint pain scores 24
Manual function test8 weeksis a performance-based assessment for upper limbs with paresis caused by stroke The MFT is graded on a four-level scale. The total MFT score can range from 0 (severely impaired) to 32 (full function)
Motor Evaluation Scale for Upper Extremity in Stroke patients8 weeksis a scale that measures the quality of movement of the hemiparetic upper extremity The maximum total score for the MESUPES is 58. The MESUPES-arm comprises 8 items of shoulder and elbow performance, with a maximum score of 40. Each item is scored from 0 (inability to adapt muscle tone to the movement) to 5 (ability to correct and complete motion without help)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026